Geneoscopy

Geneoscopy

Biotechnology, 2220 Welsch Industrial Ct, St. Louis, Missouri, 63146, United States, 51-200 Employees

geneoscopy.com

  • facebook
  • twitter
  • LinkedIn

Who is GENEOSCOPY

Geneoscopy is a life sciences company with the mission to empower patients and providers to transform gastrointestinal health through innovative diagnostics. Geneoscopys lead diagnostic u...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541715 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from GENEOSCOPY

Geneoscopy Org Chart and Mapping

Andrew Barnell

Co-Founder and Chief Executive Officer

VP-Level

Gary Gallimore

SVP of Engineering, Data Science, IT

Employees

Jacob Hall

Quality Assurance Specialist

Ryan Gorman

Vice President of Sales

Jeff Salzman

Vice President, Market Access and Revenue Cycle Management

Kimberly Kruse

Product Development Associate II

James H

Senior Devops Engineer

Lisa Small

Senior Director, Head of Clinical Affairs

Vince Wong

Chief Commercial Officer

Emily Dockter

Senior Quality Control Specialist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Geneoscopy

Answer: Geneoscopy's headquarters are located at 2220 Welsch Industrial Ct, St. Louis, Missouri, 63146, United States

Answer: Geneoscopy's official website is https://geneoscopy.com

Answer: Geneoscopy's revenue is $10 Million to $25 Million

Answer: Geneoscopy's SIC: 8731

Answer: Geneoscopy's NAICS: 541715

Answer: Geneoscopy has 51-200 employees

Answer: Geneoscopy is in Biotechnology

Answer: Geneoscopy contact info: Phone number: Website: https://geneoscopy.com

Answer: Geneoscopy is a life sciences company with the mission to empower patients and providers to transform gastrointestinal health through innovative diagnostics. Geneoscopys lead diagnostic uses stool-derived eukaryotic RNA (seRNA) to detect colorectal cancer and precancerous adenomas. This device was awarded a Breakthrough Device Designation from the FDA for its ability to reduce morbidity associated with colorectal cancer through advanced adenoma detection. Our initial prospective clinical study demonstrates that the diagnostic can detect these lesions with greater sensitivity than all existing noninvasive screening tests, thereby, serve as a potential aid in early detection and prevention of cancer. Geneoscopy is also developing diagnostics for the diagnosis and management of inflammatory bowel disease in partnership with biopharmaceutical companies and leading academic research institutions.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access